William Rafelson, MD, MBA, is a board-certified hematologist and medical oncologist with expertise in genitourinary oncology. He serves as an Attending Physician at Atlantic Health System. Clinically, he focuses on genitourinary oncology, precision oncology, and hereditary cancer risk assessment. His research interests include clinical trials and novel therapeutics in genitourinary oncology, cancer genomics and biomarker development, and outcomes and health services research to advance equitable cancer care. His work has been recognized with a National Research Service Postdoctoral Award from the NIH; he has been selected as a Castle Connolly Rising Star and named among Jersey’s Best medical oncologists. He has also demonstrated leadership by co-directing a free clinic serving underserved populations. Dr. Rafelson earned his medical degree from Rutgers Robert Wood Johnson Medical School and an MBA from Brandeis University’s Heller School; he completed an internal medicine residency at The Warren Alpert Medical School of Brown University, a hematology/oncology fellowship at Brown, and an NIH T32 postdoctoral research fellowship at Rhode Island Hospital.
Attending Physician
Medical School
2013
Residency
2013 – 2016
Fellowship
2017 – 2020